Search Results - "Di Sanza, C"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    The mTOR pathway: a new target in cancer therapy by Ciuffreda, L, Di Sanza, C, Incani, U C, Milella, M

    Published in Current cancer drug targets (01-08-2010)
    “…Mammalian target of rapamycin (mTOR) is a key protein kinase controlling signal transduction from various growth factors and upstream proteins to the level of…”
    Get more information
    Journal Article
  2. 2

    Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis by Grasselli, G, Rossi, S, Musella, A, Gentile, A, Loizzo, S, Muzio, L, Di Sanza, C, Errico, F, Musumeci, G, Haji, N, Fresegna, D, Sepman, H, De Chiara, V, Furlan, R, Martino, G, Usiello, A, Mandolesi, G, Centonze, D

    Published in British journal of pharmacology (01-01-2013)
    “…Background and Purpose Glutamate transmission is dysregulated in both multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), the animal…”
    Get full text
    Journal Article
  3. 3

    Manipulating the quality control pathway in transfected cells: low temperature allows rescue of secretion-defective fibrinogen mutants by Vu, Dung, Di Sanza, Corinne, Neerman-Arbez, Marguerite

    Published in Haematologica (Roma) (01-02-2008)
    “…1 Department of Genetic Medicine and Development, University Medical Center, Geneva; 2 Division of Angiology and Hemostasis, University Hospital, Geneva,…”
    Get full text
    Journal Article
  4. 4

    Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells by Pepper, M S, Rosnoblet, C, Di Sanza, C, Kruithof, E K

    Published in Thrombosis and haemostasis (01-08-2001)
    “…Endothelial cell migration is stimulated by members of the vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) families, and is…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia by Vu, Dung, Di Sanza, Corinne, Caille, Dorothée, de Moerloose, Philippe, Scheib, Holger, Meda, Paolo, Neerman-Arbez, Marguerite

    Published in Human molecular genetics (01-11-2005)
    “…Congenital afibrinogenemia is a rare bleeding disorder characterized by the absence in circulation of fibrinogen, a hexamer composed of two sets of three…”
    Get full text
    Journal Article
  8. 8

    Hypoxia-Inducible Angiopoietin-2 Expression Is Mimicked by Iodonium Compounds and Occurs in the Rat Brain and Skin in Response to Systemic Hypoxia and Tissue Ischemia by Mandriota, Stefano J., Pyke, Charles, Di Sanza, Corinne, Quinodoz, Pierre, Pittet, Brigitte, Pepper, Michael S.

    Published in The American journal of pathology (01-06-2000)
    “…Angiopoietins are ligands for the endothelial cell tyrosine kinase receptor Tie-2. Ang-1, the major physiological activator of Tie-2, promotes blood vessel…”
    Get full text
    Journal Article
  9. 9

    Role of Hog1 and Yaf9 in the transcriptional response of Saccharomyces cerevisiae to cesium chloride by Del Vescovo, Valerio, Casagrande, Viviana, Bianchi, Michele M, Piccinni, Eugenia, Frontali, Laura, Militti, Cristina, Fardeau, Vivienne, Devaux, Frederic, Sanza, Claudio Di, Presutti, Carlo, Negri, Rodolfo

    Published in Physiological genomics (14-03-2008)
    “…1 Istituto Pasteur Fondazione Cenci-Bolognetti, Dipartimento di Biologia Cellulare e dello Sviluppo, Università degli Studi di Roma, La Sapienza, Rome, Italy 2…”
    Get full text
    Journal Article
  10. 10

    Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution by Pepper, Michael S., Baetens, Danielle, Mandriota, Stefano J., Di Sanza, Corinne, Oikemus, Sarah, Lane, Timothy F., Soriano, Jesus V., Montesano, Roberto, Iruela‐Arispe, M. Luisa

    Published in Developmental dynamics (01-07-2000)
    “…Vascular endothelial growth factors (VEGFs) are endothelial cell‐specific mitogens with potent angiogenic and vascular permeability‐inducing properties. VEGF,…”
    Get full text
    Journal Article